SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
C4 Therapeutics approved amendment No. 2 to its 2020 plan, authorizing annual share increases of up to 5%. This corporate governance update aims to provide long-term flexibility fo…
Serina Therapeutics filed an amendment to its certificate of incorporation increasing authorized common shares to 125 million and preferred shares to 5 million. This increase provi…
JPMorgan Chase released hypothetical 2026 Dodd-Frank Act Stress Test results for a nine-quarter period under a restrictive economic scenario. The company noted the results reflect …
PIMCO Fund amended its prospectus to allow subprime and foreign loan investments, marking a significant strategic change.
The fund has amended its prospectus to permit direct lending and investment in subprime or unrated debt instruments, expanding its risk profile. This strategic shift increases pote…
PIMCO High Income Fund amended its prospectus to allow investments in subprime loans and increase common stock limits to 20%. These modifications expand the fund's risk tolerance a…
Ionis Pharmaceuticals announced the FDA approval of olezarsen (Tryngolza), a new treatment for severe hypertriglyceridemia. This marks the company's first independent commercial la…
The registrant filed a Current Report on Form 8-K dated June 24, 2026. The text was truncated immediately upon the report of Item 8.01 Other Events, preventing identification of th…
Nasdaq upheld the denial of Aditxt's listing request, suspending trading June 25. The move threatens the company's market access ahead of a shareholder vote to finalize a SPAC merg…
Femasys Inc. announced it received formal notice from Nasdaq confirming compliance with the bid price rule. This resolves a listing compliance issue and allows the company to maint…
Cognition Therapeutics received FDA feedback agreeing that DLB psychosis is an approvable outcome and aligning on its Phase 3 trial design. This regulatory milestone paves the way …
The U.S. DOE has conditionally committed $17.5 billion in loans to support ten Westinghouse nuclear reactors, leveraging Brookfield's majority ownership. This funding aims to accel…
Teucrium Commodity Trust filed a Form 8-K referencing a letter from Grant Thornton LLP. The filing confirms the senior accountant's agreement with recent disclosure statements.
NeOnc Technologies received UAE IND approval for its lead candidate NEO100 across multiple dosing protocols. This authorization complements recent UAE clearance for NEO212 and prec…
Verano Holdings Corp. filed an exhibit amending its Code of Business Conduct and Ethics. This filing updates the company's corporate governance and compliance framework.
UroGen Pharma Ltd. filed its Articles of Association as an exhibit to satisfy corporate governance requirements. This filing outlines specific operational definitions and terms nec…
The Nasdaq Hearings Panel has granted SCWorx permission to continue trading, provided the company implements a reverse stock split and meets bid price requirements. Failure to adhe…
Kimbell Royalty Partners executed a Registration Rights Agreement dated June 22, 2026, regarding Common Units transferred to Sellers in connection with an asset purchase. This docu…
Galectin Therapeutics reached an agreement with the FDA on the primary endpoint and regulatory pathway for belapectin in MASH cirrhosis patients. This alignment clarifies the Phase…
SLR International Corporation has agreed to the filing and reference of a technical report on the Sleeper Gold Mine in the company's current reports. This consent supports the comp…